Clinica de la Costa S.A.S. ( Site 0502)

Barranquilla, Atlántico 080020

0 studies enrolling now · 3 studies all time

What they study most

Advanced/Metastatic Gastroesophageal Adenocarcinoma, Carcinoma, Renal Cell, Systemic Lupus Erythematosus

Studies at this site

• A Study of Pembrolizumab (MK-3475) in Combination With Belzutifan (MK-6482) and Lenvatinib (MK-7902), or Pembrolizumab/Quavonlimab (MK-1308A) in Combination With Lenvatinib, Versus Pembrolizumab and Lenvatinib, for Treatment of Advanced Clear Cell Renal Cell Carcinoma (MK-6482-012) — Running, not enrolling
• Efficacy and Safety of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab (MK-3475) Plus Chemotherapy in Participants With Advanced/Metastatic Gastroesophageal Adenocarcinoma (MK-7902-015/E7080-G000-321/LEAP-015) — Completed
• Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) — Stopped early